BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17213975)

  • 21. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
    Tang SC
    Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.
    Weide R; Mergenthaler U; Pandorf A; Arndt H; Heymanns J; Thomalla J; Köppler H
    Onkologie; 2009 Mar; 32(3):107-13. PubMed ID: 19295249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
    Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The quality of early-stage breast cancer treatment: what can we do to improve?
    Bickell NA; Mendez J; Guth AA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):103-17, vi. PubMed ID: 15542002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surveillance in women with early breast cancer, systematic versus symptom guided follow-up].
    Welt A; Seeber S
    Zentralbl Gynakol; 2005 Aug; 127(4):213-6. PubMed ID: 16037901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M;
    CMAJ; 2001 Mar; 164(5):644-6. PubMed ID: 11258212
    [No Abstract]   [Full Text] [Related]  

  • 30. [Breast cancer].
    Saito Y; Suzuki Y; Okamura T; Tsuda B; Terada M; Terao M; Tokuda Y
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):613-6. PubMed ID: 20414016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic chemotherapy of early breast cancer (author's transl)].
    Nagel GA
    Radiol Clin (Basel); 1975; 44(4):341-9. PubMed ID: 1197677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the treatment of breast cancer in Southeast England following the introduction of national guidelines.
    Tataru D; Robinson D; Møller H; Davies E
    J Public Health (Oxf); 2006 Sep; 28(3):215-7. PubMed ID: 16644905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why institutions do not participate in ovarian cancer trials -- results from a survey in Germany.
    Sehouli J; Kostromitskaia J; Stengel D; du Bois A
    Onkologie; 2005 Jan; 28(1):13-7. PubMed ID: 15591726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
    Schmalfeldt B; du Bois A; Burges A; Emons G; Fink D; Gropp M; Hasenburg A; Jäger W; Kimmig R; Kiechle M; Kommoss F; Kreienberg R; Kuhn W; Lück HJ; Meier W; Münstedt K; Ortmann O; Pfisterer J; Richter B; Runnebaum I; Schröder W; Sehouli J; Tanner B; Wagner U; Weis J
    Zentralbl Gynakol; 2006 Feb; 128(1):11-7. PubMed ID: 16450281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dutch Institute for Healthcare Improvement guideline, "Treatment of breast carcinoma": important document but an open attitude to new "evidence" is necessary].
    de Vries EG; Willemse PH
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2120-3. PubMed ID: 12474548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer therapy and treatment guidelines.
    Holcomb SS
    Nurse Pract; 2006 Oct; 31(10):59-63. PubMed ID: 17028499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short version of the guideline "Early Detection of Breast Cancer in Germany"].
    Schulz KD; Koller M; Lorenz W; Kreienberg R; Fischer R; Albert US;
    Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):361-73. PubMed ID: 15487383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of breast cancer treatment -- a multidisciplinary approach].
    Jackisch C; Rezai M; Eiermann W; Jonat W; Kaufmann M
    Zentralbl Gynakol; 2004 Oct; 126(5):303-5. PubMed ID: 15478047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up care after breast cancer treatment.
    Loprinzi C
    Mayo Clin Womens Healthsource; 2004 Sep; 8(9):suppl 1-2. PubMed ID: 15295309
    [No Abstract]   [Full Text] [Related]  

  • 40. [There are now evidence-based guidelines for breast carcinoma. There are evidence-based guidelines for breast carcinoma. Individual therapy out? (interview by Dr. Judith Neumaier)].
    von Minckwitz G
    MMW Fortschr Med; 2002 Jun; 144(23):10. PubMed ID: 12119895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.